Platelet Rich Plasma Market to Grow at 8.3% CAGR Till 2022, Increased Bariatric and Cosmetic Surgeries Drive Market
Platelet rich plasma (PRP) is made from the patient's own blood platelets and has a concentration of platelets above the baseline. It is used for treatment of ligaments, joints, bones, and soft tissues. PRP has a concentration of platelets up to eight times more than normal blood and is thus known as enriched plasma, or platelet enriched gel. Platelet rich plasma (PRP) helps in the treatment of cardiothoracic, orthopedic, and neurological diseases, and several other ailments. Platelet rich plasma (PRP)...
View full press release